Suzanne Parker

424 total citations
7 papers, 341 citations indexed

About

Suzanne Parker is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Suzanne Parker has authored 7 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Suzanne Parker's work include Ion channel regulation and function (3 papers), Ion Transport and Channel Regulation (3 papers) and Protein Structure and Dynamics (1 paper). Suzanne Parker is often cited by papers focused on Ion channel regulation and function (3 papers), Ion Transport and Channel Regulation (3 papers) and Protein Structure and Dynamics (1 paper). Suzanne Parker collaborates with scholars based in United States, Netherlands and Japan. Suzanne Parker's co-authors include Hong-Long Ji, Dale Benos, Catherine M. Fuller, J. Edwin Blalock, Amit Gaggar, Patricia L. Jackson, Brett D. Noerager, Philip O’Reilly, Mark T. Dransfield and Bruce A. Stanton and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Suzanne Parker

7 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Parker United States 7 169 148 55 47 46 7 341
Trang T.B. Nguyen United Kingdom 7 127 0.8× 160 1.1× 252 4.6× 77 1.6× 43 0.9× 7 457
Florence Borot France 8 228 1.3× 330 2.2× 49 0.9× 54 1.1× 81 1.8× 13 547
Kate J. Treharne United Kingdom 9 193 1.1× 167 1.1× 36 0.7× 15 0.3× 29 0.6× 15 336
José-Manuel Tunon de Lara France 5 118 0.7× 91 0.6× 199 3.6× 112 2.4× 13 0.3× 5 360
Laura Pintado‐Berninches Spain 12 139 0.8× 44 0.3× 69 1.3× 41 0.9× 58 1.3× 22 288
Xia Hou United States 10 195 1.2× 78 0.5× 30 0.5× 13 0.3× 22 0.5× 17 301
Jianming Yang China 11 145 0.9× 45 0.3× 23 0.4× 52 1.1× 43 0.9× 23 341
Yuji Sugata Japan 11 57 0.3× 43 0.3× 162 2.9× 94 2.0× 28 0.6× 14 363
Zhili Lin United States 10 189 1.1× 132 0.9× 35 0.6× 41 0.9× 9 0.2× 13 403
Andrew E. Blum United States 8 120 0.7× 86 0.6× 15 0.3× 25 0.5× 45 1.0× 18 301

Countries citing papers authored by Suzanne Parker

Since Specialization
Citations

This map shows the geographic impact of Suzanne Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Parker more than expected).

Fields of papers citing papers by Suzanne Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Parker. The network helps show where Suzanne Parker may publish in the future.

Co-authorship network of co-authors of Suzanne Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Parker. A scholar is included among the top collaborators of Suzanne Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Parker. Suzanne Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Santis, Maria De, Axel Hegele, Margaret Kolb, et al.. (2019). A phase III, randomized, open-label, multicenter, global study of durvalumab and bacillus calmette-guérin (BCG) versus BCG alone in high-risk, BCG-naïve non-muscle-invasive bladder cancer (NMIBC) patients (POTOMAC).. Journal of Clinical Oncology. 37(7_suppl). TPS500–TPS500. 15 indexed citations
2.
O’Reilly, Philip, Patricia L. Jackson, Brett D. Noerager, et al.. (2009). N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respiratory Research. 10(1). 38–38. 90 indexed citations
3.
Hardison, Matthew T., F. Shawn Galin, Suzanne Parker, et al.. (2009). The Presence of a Matrix-Derived Neutrophil Chemoattractant in Bronchiolitis Obliterans Syndrome after Lung Transplantation. The Journal of Immunology. 182(7). 4423–4431. 63 indexed citations
4.
Ji, Hong-Long, et al.. (2001). Point mutations in the post-M2 region of human α-ENaC regulate cation selectivity. American Journal of Physiology-Cell Physiology. 281(1). C64–C74. 25 indexed citations
5.
Berdiev, Bakhrom K., et al.. (2001). Regions in the carboxy terminus of α-bENaC involved in gating and functional effects of actin. American Journal of Physiology-Cell Physiology. 281(1). C231–C240. 42 indexed citations
6.
Ji, Hong-Long, Biljana Jovov, Suzanne Parker, et al.. (2000). The Cytosolic Termini of the β- and γ-ENaC Subunits Are Involved in the Functional Interactions between Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel. Journal of Biological Chemistry. 275(36). 27947–27956. 92 indexed citations
7.
Shapira, Raymond & Suzanne Parker. (1960). Artificially induced microheterogeneity in ribonuclease. Biochemical and Biophysical Research Communications. 3(2). 200–204. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026